Jazz Pharmaceuticals Plc (JAZZ)
181.51
+2.96
(+1.66%)
USD |
NASDAQ |
Mar 16, 11:56
Jazz Pharmaceuticals EPS Diluted (Quarterly) : 3.207 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alkermes Plc | 0.291 |
| Amarin Corp. Plc | -0.0587 |
| Medtronic Plc | 0.8864 |
| Perrigo Co. Plc | -10.22 |
| STERIS Plc (Ireland) | 1.956 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 203.45M |
| Revenue (Quarterly) | 1.198B |
| Total Expenses (Quarterly) | 994.48M |
| Enterprise Value | 13.98B |
| Gross Profit Margin (Quarterly) | 73.01% |
| Profit Margin (Quarterly) | 16.98% |
| Earnings Yield | -3.29% |
| Operating Earnings Yield | 5.16% |
| Normalized Earnings Yield | 2.991 |